558 related articles for article (PubMed ID: 18495691)
21. Tissue plasminogen activator and urokinase plasminogen activator in human epileptogenic pathologies.
Iyer AM; Zurolo E; Boer K; Baayen JC; Giangaspero F; Arcella A; Di Gennaro GC; Esposito V; Spliet WG; van Rijen PC; Troost D; Gorter JA; Aronica E
Neuroscience; 2010 May; 167(3):929-45. PubMed ID: 20219643
[TBL] [Abstract][Full Text] [Related]
22. Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model.
Deatrick KB; Eliason JL; Lynch EM; Moore AJ; Dewyer NA; Varma MR; Pearce CG; Upchurch GR; Wakefield TW; Henke PK
J Vasc Surg; 2005 Jul; 42(1):140-8. PubMed ID: 16012463
[TBL] [Abstract][Full Text] [Related]
23. Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion.
Quemener C; Gabison EE; Naïmi B; Lescaille G; Bougatef F; Podgorniak MP; Labarchède G; Lebbé C; Calvo F; Menashi S; Mourah S
Cancer Res; 2007 Jan; 67(1):9-15. PubMed ID: 17210677
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells.
Hu PF; Zhu YW; Zhong W; Chen YX; Lin Y; Zhang X; Yin C; Yue HY; Xie WF
J Gastroenterol Hepatol; 2008 Dec; 23(12):1917-25. PubMed ID: 18761555
[TBL] [Abstract][Full Text] [Related]
25. ACE inhibition reduces activity of the plasminogen/plasmin and MMP systems in the brain of spontaneous hypertensive stroke-prone rats.
Liebetrau M; Burggraf D; Wunderlich N; Jäger G; Linz W; Hamann GF
Neurosci Lett; 2005 Mar; 376(3):205-9. PubMed ID: 15721222
[TBL] [Abstract][Full Text] [Related]
26. Growth factor-enhanced expression and activity of matrix metalloproteases in human non-small cell lung cancer cell lines.
Bredin CG; Liu Z; Klominek J
Anticancer Res; 2003; 23(6C):4877-84. PubMed ID: 14981939
[TBL] [Abstract][Full Text] [Related]
27. Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds.
Ludwig T; Eggenschwiler J; Fisher P; D'Ercole AJ; Davenport ML; Efstratiadis A
Dev Biol; 1996 Aug; 177(2):517-35. PubMed ID: 8806828
[TBL] [Abstract][Full Text] [Related]
28. Expression of protease nexin-1 and plasminogen activators during follicular growth and the periovulatory period in cattle.
Cao M; Buratini J; Lussier JG; Carrière PD; Price CA
Reproduction; 2006 Jan; 131(1):125-37. PubMed ID: 16388016
[TBL] [Abstract][Full Text] [Related]
29. CREG inhibits migration of human vascular smooth muscle cells by mediating IGF-II endocytosis.
Han Y; Cui J; Tao J; Guo L; Guo P; Sun M; Kang J; Zhang X; Yan C; Li S
Exp Cell Res; 2009 Nov; 315(19):3301-11. PubMed ID: 19769965
[TBL] [Abstract][Full Text] [Related]
30. Microglial low-density lipoprotein receptor-related protein 1 mediates the effect of tissue-type plasminogen activator on matrix metalloproteinase-9 activity in the ischemic brain.
Zhang C; An J; Haile WB; Echeverry R; Strickland DK; Yepes M
J Cereb Blood Flow Metab; 2009 Dec; 29(12):1946-54. PubMed ID: 19672275
[TBL] [Abstract][Full Text] [Related]
31. Actinobacillus actinomycetemcomitans lipopolysaccharide regulates matrix metalloproteinase, tissue inhibitors of matrix metalloproteinase, and plasminogen activator production by human gingival fibroblasts: a potential role in connective tissue destruction.
Bodet C; Andrian E; Tanabe S; Grenier D
J Cell Physiol; 2007 Jul; 212(1):189-94. PubMed ID: 17299802
[TBL] [Abstract][Full Text] [Related]
32. Expression and activation of MMP -2, -3, -9, -14 are induced in rat colon after abdominal X-irradiation.
Strup-Perrot C; Vozenin-Brotons MC; Vandamme M; Benderitter M; Mathe D
Scand J Gastroenterol; 2006 Jan; 41(1):60-70. PubMed ID: 16373278
[TBL] [Abstract][Full Text] [Related]
33. Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue.
Knappe UJ; Hagel C; Lisboa BW; Wilczak W; Lüdecke DK; Saeger W
Acta Neuropathol; 2003 Nov; 106(5):471-8. PubMed ID: 12904990
[TBL] [Abstract][Full Text] [Related]
34. Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition.
Norwitz ER; Snegovskikh V; Schatz F; Foyouzi N; Rahman M; Buchwalder L; Lee HJ; Funai EF; Buhimschi CS; Buhimschi IA; Lockwood CJ
Am J Obstet Gynecol; 2007 Apr; 196(4):382.e1-8. PubMed ID: 17403427
[TBL] [Abstract][Full Text] [Related]
35. Stretch-induced membrane type matrix metalloproteinase and tissue plasminogen activator in cardiac fibroblast cells.
Tyagi SC; Lewis K; Pikes D; Marcello A; Mujumdar VS; Smiley LM; Moore CK
J Cell Physiol; 1998 Aug; 176(2):374-82. PubMed ID: 9648925
[TBL] [Abstract][Full Text] [Related]
36. Influence of exogenous growth factors on the expression of plasminogen activators and plasminogen activator inhibitors by cells isolated from normal and healing rabbit ligaments.
Murphy PG; Hart DA
J Orthop Res; 1994 Jul; 12(4):564-75. PubMed ID: 7520487
[TBL] [Abstract][Full Text] [Related]
37. Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis.
He Y; Liu XD; Chen ZY; Zhu J; Xiong Y; Li K; Dong JH; Li X
Clin Cancer Res; 2007 Jun; 13(11):3115-24. PubMed ID: 17545513
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of fibroblast growth factors on expression of genes of the plasminogen activator and insulin-like growth factor systems by human breast fibroblasts.
Sieuwerts AM; Martens JW; Dorssers LC; Klijn JG; Foekens JA
Thromb Haemost; 2002 Apr; 87(4):674-83. PubMed ID: 12008951
[TBL] [Abstract][Full Text] [Related]
39. Effect of intrafollicular indomethacin injection on gonadotropin surge-induced expression of select extracellular matrix degrading enzymes and their inhibitors in bovine preovulatory follicles.
Li Q; Jimenez-Krassel F; Kobayashi Y; Ireland JJ; Smith GW
Reproduction; 2006 Mar; 131(3):533-43. PubMed ID: 16514196
[TBL] [Abstract][Full Text] [Related]
40. Cardiomyoblast apoptosis induced by insulin-like growth factor (IGF)-I resistance is IGF-II dependent and synergistically enhanced by angiotensin II.
Kuo WW; Liu CJ; Chen LM; Wu CH; Chu CH; Liu JY; Lu MC; Lin JA; Lee SD; Huang CY
Apoptosis; 2006 Jul; 11(7):1075-89. PubMed ID: 16699953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
